Medical adjuncts in IVF: evidence for clinical practice

References

• Abadia-Molina A. C., Ruiz C., Montes M. J., King A., Loke Y. W., Olivares E. G. Immune phenotype and cytotoxic activity of lymphocytes from human term decidua against trophoblast. Journal of Reproductive Immunology 1996; 31: 109–123
   Google Scholar
• Abir R., Garor R., Felz C., Nitke S., Krissi H., Fisch B. Growth hormone and its receptor in human ovaries from fetuses and adults. Fertility and Sterility 2008; 90(4 Suppl)1333–1339
   Google Scholar
• Ando T., Suganuma N., Furuhashi M., Asada Y., Kondo I., Tomoda Y. Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer. Journal of Assisted Reproduction and Genetics 1996; 13: 776–781
   PubMed Web of Science ®Google Scholar
• Balasch J., Creus M., Fabregues F., Font J., Martorell J., Vanrell J. A. Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer. Fertility and Sterility 1996; 65: 655–658
   Google Scholar
• Beckers N. G. M., Laven J. S., Eijkemans M. J. C., Fauser B. C. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization. Human Reproduction 2000; 15: 43–49
   PubMed Web of Science ®Google Scholar
• Beer A. E., Kwak J. Y., Ruiz J. E. Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. American Journal of Reproductive Immunology 1996; 35: 376–382
   PubMed Web of Science ®Google Scholar
• Birkenfeld A., Mukaida T., Minichiello L., Jackson M., Kase N. G., Yemini M. Incidence of autoimmune antibodies in failed embryo transfer cycles. American Journal of Reproductive Immunology 1994; 31: 65–68
   PubMed Web of Science ®Google Scholar
• Bisset L. R., Lung T. L., Kaelin M., Ludwig E., Dubs R. W. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland. European Journal of Haematology 2004; 72: 203–212
   PubMed Web of Science ®Google Scholar
• Boomsma C. M., Keay S. D., Macklon N. S. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. The Cochrane Database of Systematic Review 2007, Art no.: CD005996
   Google Scholar
• Chamley L. W., Duncalf A. M., Mitchell M. D., Johnson P. M. Action of anticardiolipin and antibodies to β2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998; 352: 1037–1038
   PubMed Web of Science ®Google Scholar
• Check J. H., Choe J. K., Ubelacker L., DiAntonio A. Maternal/paternal sharing of DQ-α type II histocompatibility antigens not associated with pregnancy outcome following in vitro fertilization (IVF)-embryo transfer (ET). Clinical and Experimental Obstetrics & Gynecology 2001; 28: 142–143
   Google Scholar
• Check J. H., Graziano V., Lee G., Nazari A., Choe J. K., Dietterich C. Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clinical and Experimental Obstetrics & Gynecology 2004; 31: 99–102
   PubMedGoogle Scholar
• Coulam C. B., Goodman C. Increased pregnancy rates after IVF/ET with intravenous immunoglobulin treatment in women with elevated circulating C56+ cells. Early Pregnancy 2000; 4: 90–98
   Google Scholar
• Coulam C. B., Roussev R. G. Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer. Journal of Assisted Reproduction and Genetics 2003; 20: 58–62
   PubMedGoogle Scholar
• Coulam C. B., Krysa L. W., Bustillo M. Intravenous immunoglobulin for in-vitro fertilization failure. Human Reproduction 1994; 9: 2265–2269
   PubMed Web of Science ®Google Scholar
• Creus M., Balasch J., Fabregues F., Martorell J., Boada M., Penarrubia J., et al. Parental human leukocyte antigens and implantation failure after in-vitro fertilization. Human Reproduction 1998; 13: 39–43
   Google Scholar
• Cubillos J., Lucena A., Lucena C., Mendoza J. C., Ruiz H., Arango A., et al. Incidence of autoantibodies in the infertile population. Early Pregnancy 1997; 3: 119–124
   PubMedGoogle Scholar
• Denis A. L., Guido M., Adler R. D., Bergh P. A., Brenner C., Scott R. T., Jr. Antiphospholipid antibodies and pregnancy rates and outcome in in-vitro fertilization patients. Fertility and Sterility 1997; 67: 1084–1090
   PubMed Web of Science ®Google Scholar
• Department of Health. Clinical guidelines for immunoglobulin use2nd ed. Department of Health, UK. 2008
   Google Scholar
• Devreker F., Govaerts I., Bertrand E., Van den Bergh M., Gervy C., Englert Y. The long acting gonadotrophin releasing hormone analogues impaired the implantation rate. Fertility and Sterility 1996; 65: 122–126
   PubMed Web of Science ®Google Scholar
• Di Simone N., Meroni P. L., de Papa N., Raschi E., Caliandro D., De Carolis C. S., et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2-glycoprotein I. Arthritis and Rheumatism 2000; 43: 140–150
   PubMed Web of Science ®Google Scholar
• Dor J., Seidman D. S., Amudai E., Bider D., Levran D., Mashiach S. Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study. Human Reproduction 1995; 10: 40–43
   PubMed Web of Science ®Google Scholar
• Dosiou C., Giudice L. C. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocrine Reviews 2005; 26: 44–62
   PubMed Web of Science ®Google Scholar
• Eldar-Geva T., Wood C., Lolatgis N., Rombauts L., Kovacs G., Fuscaldo J., et al. Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Human Reproduction 1999; 14: 1461–1466
   Google Scholar
• Elram T., Simon A., Israel S., Revel A., Shveiky D., Laufer N. Treatment of recurrent IVF failure and human leukocyte antigen similarity by intravenous immunoglobulin. Reproductive BioMedicine Online 2005; 11: 745–749
   PubMed Web of Science ®Google Scholar
• Empson M., Lassere M., Craig J., Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Systematic Reviews 2005, Art no.: CD002859
   Google Scholar
• Engmann L., Diluigi A., Schmidt D., Nulsen J., Maier D., Benadiva C. The use of gonadotropin-releasing hormone (GnRH-a) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertility and Sterility 2008a; 89: 84–91
   PubMed Web of Science ®Google Scholar
• Engmann L., Diluigi A., Schmidt D., Benadiva C., Maier D., Nulsen J. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Fertility and Sterility 2008b; 89: 554–561
   PubMed Web of Science ®Google Scholar
• Fahri J., Weissman A., Steinfeld Z., Shorer M., Nahum H., Levran D. Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertility and Sterility 2000; 73: 761–765
   Google Scholar
• Fanchin R., Righini C., Olivennes F., Taylor S., de Ziegler D., Frydman R. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Human Reproduction 1998; 13: 1968–1974
   PubMed Web of Science ®Google Scholar
• Fasouliotis S. J., Spandorfer S. D., Witkin S. S., Schattman G., Liu H. C., Roberts J. E., et al. Maternal serum levels of interferon-γ and interleukin-2 soluble receptor-α predict the outcome of early IVF pregnancies. Human Reproduction 2004; 19: 1357–1363
   PubMed Web of Science ®Google Scholar
• Frattarelli J. L., McWilliams G. D., Hill M. J., Miller K. A., Scott R. T., Jr. Low dose aspirin use does not improve in vitro fertilization outcomes in poor responders. Fertility and Sterility 2008; 89: 1113–1117
   PubMed Web of Science ®Google Scholar
• Gelbaya T. A., Kyrgiou M., Li T. C., Stern C., Nardo L. G. Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis. Human Reproduction Update 2007; 13: 357–364
   PubMed Web of Science ®Google Scholar
• Gelbaya T. A., Kyrgiou M., Nardo L. G. Letter to the editor – reply: ‘Is it time for meta-analysis?’. Human Reproduction Update, in press
   Google Scholar
• Gelbaya T. A., Kyrgiou M., Tsoumpou I., Nardo L. G. The use of estradiol for luteal phase support in in-vitro fertilization/intracytoplasmic sperm injection cycles: a systematic review and meta-analysis. Fertility and Sterility 2008; 90: 2116–2125
   PubMed Web of Science ®Google Scholar
• Geva E., Yaron Y., Lessing J. B., Yovel I., Vardinon N., Burke M., et al. Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertility and Sterility 1994; 62: 802–806
   PubMed Web of Science ®Google Scholar
• Geva E., Vardinon N., Lessing J. B., Lerner-Geva L., Azem F., Yovel I., et al. Organ-specific autoantibodies are possible markers for reproductive failure: a prospective study in an in-vitro fertilization-embryo transfer programme. Human Reproduction 1996; 11: 1627–1631
   PubMed Web of Science ®Google Scholar
• Geva E., Amit A., Lerner-Geva L., Yaron Y., Daniel Y., Schwartz T., et al. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. American Journal of Reproductive Immunology 2000; 43: 36–40
   PubMed Web of Science ®Google Scholar
• Gorkemli H., Ak D., Akyurek C., Aktan M., Duman S. Comparison of pregnancy outcomes of progesterone or progesterone + estradiol for luteal phase support in ICSI-ET cycles. Gynecologic and Obstetric Investigation 2004; 58: 140–144
   PubMed Web of Science ®Google Scholar
• Goswamy R. K., Steptoe P. C. Doppler ultrasound studies of the uterine artery in spontaneous ovarian cycles. Human Reproduction 1988; 3: 721–726
   PubMed Web of Science ®Google Scholar
• Harper K., Proctor M., Hughes E. Growth hormone for in vitro fertilization. Cochrane Database Systematic Review 2003, Issue 3, Art no.: CD000099
   Google Scholar
• Hasegawa I., Yamanoto Y., Suzuki M., Murakawa H., Kurabayashi T., Takakuwa K., et al. Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertility and Sterility 1998; 70: 1044–1048
   PubMed Web of Science ®Google Scholar
• Ho H. N., Yang Y. S., Hsieh R. P., Lin H. R., Chen S. U., Chen H. F., et al. Sharing of human leukocyte antigens in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer. American Journal of Obstetrics and Gynecology 1994; 170: 63–71
   PubMed Web of Science ®Google Scholar
• Hornstein M. D., Davis O. K., Massey J. B., Paulson R. J., Collins J. A. Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertility and Sterility 2000; 73: 330–333
   PubMed Web of Science ®Google Scholar
• Hurst B. S., Bhojwani J. T., Marshburn P. B., Papadakis M. A., Loeb T. A., Matthews M. L. Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization. Journal of Experimental & Clinical Assisted Reproduction 2005; 31: 2–8
   Google Scholar
• Hutchinson-Williams K., Lunenfeld B., Diamond M., Lagy G., Boyers S., De Cherney A. Human chorionic gonadotropin, estradiol, and progesterone profiles in conception and non-conception cycles in an in vitro fertilization program. Fertility and Sterility 1989; 52: 441–445
   PubMed Web of Science ®Google Scholar
• Kaider A. S., Kaider B. D., Janowicz P. B., Roussev R. G. Immunodiagnostic evaluation in women with reproductive failure. American Journal of Reproductive Immunology 1999; 42: 335–346
   PubMed Web of Science ®Google Scholar
• Kalu E., Bhaskaran S., Thum M. Y., Vishwanatha R., Croucher C., Sherriff E., et al. Serial estimation of Th1:Th2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer. American Journal of Reproductive Immunology 2008; 59: 206–211
   PubMed Web of Science ®Google Scholar
• Katz U., Achiron A., Sherer Y., Shoenfeld Y. Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmunity Reviews 2007; 6: 257–259
   PubMed Web of Science ®Google Scholar
• Khairy M., Banerjee K., El-Toukhy T., Coomarasamy A., Khalaf Y. Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis. Fertility and Sterility 2007; 88: 822–831
   PubMed Web of Science ®Google Scholar
• Kikuchi K., Shibahara H., Hirano Y., Kohno T., Hirashima C., Suzuki T., et al. Antinuclear antibody reduces the pregnancy rate in the first IVF-ET treatment cycle but not the cumulative pregnancy rate without specific medication. American Journal of Reproductive Immunology 2003; 50: 363–367
   PubMed Web of Science ®Google Scholar
• Kim C. H., Chae H. D., Chang Y. S. Pyridostigmine cotreatment for controlled ovarian hyperstimulatiom in low responders undergoing in vitro fertilization embryo transfer. Fertility and Sterility 1999; 71: 652–657
   PubMed Web of Science ®Google Scholar
• Knutzen V., Stratton C. J., Sher G., McNamee P. I., Huang T. T., Soto-Albors C. Mock embryo transfer in early luteal phase, the cycle before in vitro fertilization and embryo transfer: a descriptive study. Fertility and Sterility 1992; 57: 156–162
   Google Scholar
• Kozer E., Nikfar S., Costei A., Boskovic R., Nulman I., Koren G. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. American Journal of Obstetrics & Gynecology 2002; 187: 1623–1630
   PubMed Web of Science ®Google Scholar
• Kucuk T., Kozinoglu H., Kaba A. Growth hormone co-treatment within a GnRH-agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. Journal of Assisted Reproduction and Genetics 2008; 25: 123–127
   PubMed Web of Science ®Google Scholar
• Kutteh W. H., Yetman D. L., Chantilis S. J., Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Human Reproduction 1997; 12: 1171–1175
   PubMed Web of Science ®Google Scholar
• Kutteh W. H., Yetman D. L., Carr A. C., Beck L. A., Scott R. T., Jr. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertility and Sterility 1999a; 71: 843–848
   PubMed Web of Science ®Google Scholar
• Kutteh W. H., Schoolcraft W. B., Scott R. T., Jr. Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Human Reproduction 1999b; 14: 2886–2890
   PubMed Web of Science ®Google Scholar
• Kwak-Kim J. Y., Ching-Bang H. S., Ng S. C., Ntrivalas E. I., Mangubat C. P., Beaman K. D., et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Human Reproduction 2003; 18: 767–773
   PubMed Web of Science ®Google Scholar
• Lee S. R., Park E. J., Kim S. H., Chae H., Kim C. H., Kang B. M. Influence of antiphospholipid antibodies on pregnancy outcome in women undergoing in vitro fertilization and embryo transfer. American Journal of Reproductive Immunology 2007; 57: 34–39
   Google Scholar
• Lesny P., Killick S. R., Tetlow R. L., Robinson J., Maguiness S. D. Uterine junctional zone contractions during assisted reproduction cycles. Human Reproduction Update 1998; 4: 440–445
   PubMed Web of Science ®Google Scholar
• Lewin A., Benshushan A., Mezker E., Yanai N., Schenker J., Goshen R. The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone support. Fertility and Sterility 1994; 62: 212–225
   Google Scholar
• Lim W, Crowther M. A. Antiphospholipid antibiodies: a critical review of the literature. Current Opininon in Hematology 2007; 14: 494–499
   Google Scholar
• Lok I. H., Yip S., Cheung L. P. Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertility and Sterility 2004; 81: 556–561
   PubMed Web of Science ®Google Scholar
• Luborsky J., Llanes B., Davies S., Binor Z., Radwanska E., Pong R. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clinical Immunology 1999; 90: 368–374
   PubMed Web of Science ®Google Scholar
• Lukaszuk K., Liss J., Lukaszuk M., Maj B. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles. Fertility and Sterility 2005; 83: 1372–1376
   PubMed Web of Science ®Google Scholar
• Martin-Villa J. M., De Juan D., Vicario J. L., Luque I. M., Alvarez E., Cortes-Prieto J., et al. HLA class I, class II, and class III antigen sharing is not found in couples with unexplained infertility. International Journal of Fertility and Menopausal Studies 1993; 38: 280–288
   Google Scholar
• Matteo M. G., Greco P., Rosenberg P., Mestice A., Baldini D., Falagario T., et al. Normal percentage of CD56bright natural killer cells in young patients with a history of repeated unexplained implantation failure after in vitro fertilization cycles. Fertility and Sterility 2007; 88: 990–993
   Google Scholar
• Miyakis S., Lockshin M. D., Atsumi T., Branch D. W., Brey R. L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis 2006; 4: 295–306
   PubMed Web of Science ®Google Scholar
• Moffett-King A. Natural killer cells and pregnancy. Nature Reviews Immunology 2002; 2: 656–663
   PubMed Web of Science ®Google Scholar
• Morizaki N., Morizaki J., Hayashi R. H., Garfield R. E. A functional and structural study of the innervation of the human uterus. American Journal of Obstetrics and Gynecology 1989; 160: 218–228
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. Fertility: assessment and treatment for people with fertility problems. Clinical Guideline 2004; 11: 12.3
   Google Scholar
• Negro R., Formoso G., Coppola L., Presicce G., Mangieri T., Pezzarossa A., et al. Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function. Journal of Endocrinological Investigation 2007; 30: 3–8
   PubMed Web of Science ®Google Scholar
• Nelson S M, Greer I. A. The potential role of heparin in assisted conception. Human Reproduction Update 2008; 14: 623–645
   PubMed Web of Science ®Google Scholar
• Ng S. C., Gilman-Sachs A., Thaker P., Beaman K. D., Beer A. E., Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. American Journal of Reproductive Immunology 2002; 48: 77–86
   PubMed Web of Science ®Google Scholar
• Nordlander C., Fuchs T., Hammarstrom L., Smith C. I. Human leukocyte antigens group A in couples with unexplained infertility. Fertility and Sterility 1983; 40: 60–65
   Google Scholar
• Ohl J., Lefebvre-Maunoury C., Wittemer C., Nisand G., Laurent M. C., Hoffmann P. Nitric oxide donors for patients undergoing IVF. A prospective, double-blind, randomized, placebo-controlled trial. Human Reproduction 2002; 17: 2615–2620
   PubMed Web of Science ®Google Scholar
• Okazaki M., Matsuyama T., Kohno T., Shindo H., Koji T., Morimoto Y., et al. Induction of epithelial cell apoptosis in the uterus by a mouse uterine ischemia-reperfusion model: possible involvement of tumor necrosis factor-alpha. Biology of Reproduction 2005; 72: 1282–1288
   PubMed Web of Science ®Google Scholar
• Omu A. E., al-Qattan F., Ismail A. A., al-Taher S., al-Busiri N. Relationship between unexplained infertility and human leukocyte antigens and expression of circulating autogeneic and allogeneic antisperm antibodies. Clinical and Experimental Obstetrics and Gynecology 1999; 26: 199–202
   PubMedGoogle Scholar
• Opatrny L., David M., Kahn S. R., Shrier I., Rey E. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a meta-analysis. Journal of Rheumatology 2006; 33: 2214–2221
   PubMed Web of Science ®Google Scholar
• Päkkilä M., Räsänen J., Heinonen S., Tinkanen H., Tuomivaara L., Mäkikallio K., et al. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. Human Reproduction 2005; 20: 2211–2214
   Google Scholar
• Patrono C., Garcia Rodriguez L. A., Landolfi R., Baigent C. Low-dose aspirin for the prevention of atherosclerosis. New England Journal of Medicine 2005; 353: 2373–2383
   PubMed Web of Science ®Google Scholar
• Pinheiro O. L., Cavagna M., Baruffi R. L. R., Mauri A. L., Petersen C., Franco J. G., Jr. Administration of β2-adrenergic agonists during the peri-implantation period does not improve implantation or pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles. Journal of Assisted Reproduction and Genetics 2003; 20: 513–516
   PubMed Web of Science ®Google Scholar
• Pires E. S., Meherji P. K., Vaidya R. R., Parikh F. R., Ghosalkar M. N., Khole V. V. Specific and sensitive immunoassays detect multiple anti-ovarian antibodies in women with infertility. The Journal of Histochemistry and Cytochemistry 2007; 55: 1181–1190
   Google Scholar
• Qublan H. S., Eid S. S., Ababneh H. A., Amarin Z. O., Smadi A. Z., Al-Khafaji F. F., et al. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Human Reproduction 2006; 21: 2694–2698
   PubMed Web of Science ®Google Scholar
• Quenby S., Bates M., Doig T., Brewster J., Lewis-Jones D. I., Johnson P. M., et al. Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Human Reproduction 1999; 14: 2386–2391
   PubMed Web of Science ®Google Scholar
• Revelli A., Dolfin E., Gennarelli G., Lantieri T., Massobrio M., Holte J. G., et al. Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study. Fertility and Sterility 2008; 90: 1685–1691
   PubMed Web of Science ®Google Scholar
• Rogolino A., Coccia M. E., Fedi S., Gori A. M., Cellai A. P., Scarselli G. F., et al. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagulation & Fibrinolysis 2003; 14: 277–282
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynaecologists. Scientific Advisory Committee Opinion Paper 5. Immunological testing and interventions for reproductive failure. 2008, Available at: http://www.rcog.org.uk/resources/Public/pdf/SAC_Paper_5
   Google Scholar
• Rubinstein M., Marazzi A., Polak D. F. Low dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized double blind placebo controlled assay. Fertility and Sterility 1999; 71: 825–829
   PubMed Web of Science ®Google Scholar
• Ruopp M. D., Collins T. C., Whitcomb B. W., Schisterman E. F. Evidence of absence or absence of evidence? A re-analysis of the effects of low-dose aspirin in in-vitro fertilization. Fertility and Sterility 2008; 90: 71–76
   PubMed Web of Science ®Google Scholar
• Schenk L. M., Butler L., Monis J. P., Cox B., Leete J., Abuhamed A., et al (1996) Heparin and aspirin treatment yields higher implantation rates in IVF patients with antiphospholipid antibody seropositivity compared to untreated seronegative patients. Fifty-Second Annual Meeting of the American Society for Reproductive Medicine, Boston, MAUSA, Nov, 2–61996
   Google Scholar
• Sengupta J., Dhawan L., Lalitkumar P G. L., Ghosh D. Nitric oxide in blastocyst implantation in the rhesus monkey. Reproduction 2005; 130: 321–332
   PubMed Web of Science ®Google Scholar
• Serna J., Cholquevilque J. L., Cela V., Martinez-Salazar J., Requena A., Garcia-Velasco J. A. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial. Fertility and Sterility 2008; 90: 2190–2195
   PubMed Web of Science ®Google Scholar
• Shaker A. G., Fleming R., Jamieson M. E., Yates R. W., Coutts J. R. Assessments of embryo transfer after in-vitro fertilization: effects of glyceryl trinitrate. Human Reproduction 1993; 8: 1426–1428
   PubMed Web of Science ®Google Scholar
• Sher G., Fisch J. D. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Human Reproduction 2000; 15: 806–809
   PubMed Web of Science ®Google Scholar
• Sher G., Maassarani G., Zouves C., Feinman M., Sohn S., Matzner W., et al. The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. American Journal of Reproductive Immunology 1998a; 39: 223–225
   PubMed Web of Science ®Google Scholar
• Sher G., Matzner W., Feinman M., Maassarani G., Zouves C., Chong P., et al. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. American Journal of Reproductive Immunology 1998b; 40: 74–82
   PubMed Web of Science ®Google Scholar
• Sher G., Zouves C., Feinman M., Maassarani G., Matzner W., Chong P., et al. A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. American Journal of Reproductive Immunology 1998c; 39: 391–394
   PubMed Web of Science ®Google Scholar
• Sherer Y., Levy Y., Langevitz P., Rauova L., Fabrizzi F., Shoenfeld Y. Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases. Pharmacology 2001; 62: 133–137
   PubMed Web of Science ®Google Scholar
• Smitz J., Bourgain C., Van Waesberghe L., Camus M., Devroey P., Van Steirteghem A. A prospective randomized study on estradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Human Reproduction 1993; 8: 40–45
   PubMed Web of Science ®Google Scholar
• Steer C. V., Campbell S., Tan S. L., Crayford T., Millis C., Mason B. A., et al. The use of transvaginal color flow imaging after in vitro fertilization identifies optimum uterine conditions before embryo transfer. Fertility and Sterility 1992; 57: 372–376
   PubMed Web of Science ®Google Scholar
• Stephenson M. D., Fluker M. R. Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial. Fertility and Sterility 2000; 74: 1108–1113
   PubMed Web of Science ®Google Scholar
• Stern C., Chamley L., Hale L., Kloss M., Speirs A., Baker H. W. Antibodies to beta2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of a prevalence study. Fertility and Sterility 1998; 70: 938–944
   PubMedGoogle Scholar
• Stern C., Chamley L., Norris H., Hale L., Baker H. W. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertility and Sterility 2003; 80: 376–383
   PubMed Web of Science ®Google Scholar
• Taniguchi F. Results of prednisolone given to improve the outcome of in vitro fertilization-embryo transfer in women with antinuclear antibodies. Journal of Reproductive Medicine 2005; 50: 383–388
   PubMed Web of Science ®Google Scholar
• Tay P. Y.S., Lenton E. A. Inhibition of progesterone secretion by oestradiol administration in the luteal phase of assisted conception cycles. Medical Journal of Malaysia 2003; 58: 187–195
   PubMedGoogle Scholar
• Thum M. Y., Bhaskaran S., Abdalla H. I., Ford B., Sumar N., Shehata H., et al. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Human Reproduction 2004; 19: 2395–2400
   PubMed Web of Science ®Google Scholar
• Thum M. Y., Abdalla H. I., Bhaskaran S., Harden E. L., Ford B., Sumar N., et al. The relationship of systemic TNF-α and IFN-γ with IVF treatment outcome and peripheral blood NK cells. American Journal of Reproductive Immunology 2007; 57: 210–217
   PubMed Web of Science ®Google Scholar
• Urman B., Mercan R., Alatas C., Balaban B., Isiklar A., Nuhoglu A. Low dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study. Journal of Assisted Reproduction and Genetics 2000; 17: 586–590
   PubMedGoogle Scholar
• van Gestel I., Ijland M. M., Hoogland H. J., Evers J. L. Endometrial wave-like activity in the non-pregnant uterus. Human Reproduction Update 2003; 9: 131–138
   PubMed Web of Science ®Google Scholar
• Waldenström U., Hellberg D., Nilsson S. Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study. Fertility and Sterility 2004; 81: 1560–1564
   PubMed Web of Science ®Google Scholar
• Weckstein L. N., Jacobson A., Galen D., Hampton K., Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertility and Sterility 1997; 68: 927–930
   PubMed Web of Science ®Google Scholar
• Wilson W. A., Gharavi A. E., Koike T., Lockshin M. D., Branch D. W., Piette J. C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis and Rheumatism 1999; 42: 1309–1311
   PubMed Web of Science ®Google Scholar
• Yetman D. L., Kutteh W. H., Castorena R., Brown C., Baskin L. Prevalence of elevated anticardiolipin antibodies in pregnant women with unexplained elevations of alpha-fetoprotein. Journal of Reproductive Immunology 1997; 33: 71–81
   Google Scholar
• Younis S., Ezra Y., Sherman Y., Simon A., Schencker G., Laufer N. The effect of estradiol depletion during the luteal phase on endometrium development. Fertility and Sterility 1994; 62: 103–107
   PubMed Web of Science ®Google Scholar
• Zhang X., Wang H. M., Lin H. Y., Liu G. Y., Li Q. L., Zhu C. Regulation of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) during mouse peri-implantation: role of nitric oxide. Placenta 2004; 25: 243–252
   PubMed Web of Science ®Google Scholar